Novavax reported $438.09M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US USD 141.37M 1.56M
Agenus AGEN:US USD 13.46M 241K
AstraZeneca AZN:LN USD 29.3B 229M
Astrazeneca AZN:US USD 29.3B 229M
Biocryst Pharmaceuticals BCRX:US USD 713.65M 91.47M
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Mannkind MNKD:US USD 377.03M 564K
Moderna Inc MRNA:US USD 1.15B 384M
Novartis NVS:US USD 28.44B 2.59B
Novavax NVAX:US USD 438.09M 10.34M
Peregrine Pharmaceuticals PPHM:US USD 142.44M 134K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Tg Therapeutics TGTX:US USD 70.04M 1.09M